OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Andrej Belančić, Andrea Kresović, Marija Dijan
Clinical Obesity (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Drug Therapies for Diabetes
Roni Weinberg Sibony, Omri Segev, Saar Dor, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17147-17147
Open Access | Times Cited: 22
Roni Weinberg Sibony, Omri Segev, Saar Dor, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17147-17147
Open Access | Times Cited: 22
Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process
Marcin Hachuła, Michał Kosowski, Sabina Ryl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1854-1854
Open Access | Times Cited: 10
Marcin Hachuła, Michał Kosowski, Sabina Ryl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1854-1854
Open Access | Times Cited: 10
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, et al.
Diabetes Research and Clinical Practice (2021) Vol. 179, pp. 109031-109031
Open Access | Times Cited: 52
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, et al.
Diabetes Research and Clinical Practice (2021) Vol. 179, pp. 109031-109031
Open Access | Times Cited: 52
Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
Lili Yu, Xiaoying Zhang, Sarah Ye, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 27
Lili Yu, Xiaoying Zhang, Sarah Ye, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 27
Comorbidities of COVID-19 Patients
Radu Silaghi‐Dumitrescu, Iulia Patrascu, Maria Lehene, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1393-1393
Open Access | Times Cited: 19
Radu Silaghi‐Dumitrescu, Iulia Patrascu, Maria Lehene, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1393-1393
Open Access | Times Cited: 19
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
Juan Pang, Jia Nuo Feng, Wenhua Ling, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4040-4055
Open Access | Times Cited: 25
Juan Pang, Jia Nuo Feng, Wenhua Ling, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4040-4055
Open Access | Times Cited: 25
Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID ‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1683-1693
Open Access | Times Cited: 7
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1683-1693
Open Access | Times Cited: 7
Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11
Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease
Radica Z. Alicic, Joshua J. Neumiller
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 201-201
Open Access | Times Cited: 5
Radica Z. Alicic, Joshua J. Neumiller
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 201-201
Open Access | Times Cited: 5
Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 1
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 1
Beyond Blood Sugar: Low Awareness of Kidney Disease among Type 2 Diabetes Mellitus Patients in Dalmatia—Insights from the First Open Public Call
Josipa Radić, Marijana Vučković, Hana Đogaš, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1643-1643
Open Access | Times Cited: 1
Josipa Radić, Marijana Vučković, Hana Đogaš, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1643-1643
Open Access | Times Cited: 1
Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension
Jong Han Lee
Medical Hypotheses (2021) Vol. 158, pp. 110739-110739
Open Access | Times Cited: 12
Jong Han Lee
Medical Hypotheses (2021) Vol. 158, pp. 110739-110739
Open Access | Times Cited: 12
Crosstalk between SARS-CoV-2 Infection and Type II Diabetes
Asim Azhar, Wajihul Hasan Khan, Khaled Alhosaini, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 25, Iss. 14, pp. 2429-2442
Closed Access | Times Cited: 7
Asim Azhar, Wajihul Hasan Khan, Khaled Alhosaini, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 25, Iss. 14, pp. 2429-2442
Closed Access | Times Cited: 7
Targeting and Modulation of the Natriuretic Peptide System in Covid-19: A Single or Double-Edged Effect?
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Protein and Peptide Science (2022) Vol. 23, Iss. 5, pp. 321-334
Closed Access | Times Cited: 6
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Protein and Peptide Science (2022) Vol. 23, Iss. 5, pp. 321-334
Closed Access | Times Cited: 6
Effects of the Na+/H+ Ion Exchanger on Susceptibility to COVID-19 and the Course of the Disease
Medine Cumhur Cüre, Erkan Cüre
Journal of the Renin-Angiotensin-Aldosterone System (2021) Vol. 2021
Open Access | Times Cited: 8
Medine Cumhur Cüre, Erkan Cüre
Journal of the Renin-Angiotensin-Aldosterone System (2021) Vol. 2021
Open Access | Times Cited: 8
Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach
Shilpi Kashyap, Rajni Bala, Reecha Madaan, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 27, pp. 35429-35436
Open Access | Times Cited: 7
Shilpi Kashyap, Rajni Bala, Reecha Madaan, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 27, pp. 35429-35436
Open Access | Times Cited: 7
The impact of preadmission/prediagnosis use of GLP‐1 receptor agonists on COVID‐19 mortality in patients with diabetes: A systematic review and meta‐analysis
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 2
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 2
Fasting GLP-1 Levels and Albuminuria Are Negatively Associated in Patients with Type 2 Diabetes Mellitus
Cheol-Won Jang, Tae Yang Yu, Jin Woo Jeong, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 280-280
Open Access
Cheol-Won Jang, Tae Yang Yu, Jin Woo Jeong, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 280-280
Open Access
The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury
Anja Harej, Kristina Pilipović, Andrej Belančić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1313-1313
Open Access
Anja Harej, Kristina Pilipović, Andrej Belančić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1313-1313
Open Access
Human microbiome and diabetes
Renz Romerino M. Pizarro, M. Guzman, Sushmitha Gururagavendiran, et al.
Elsevier eBooks (2024), pp. 69-76
Closed Access
Renz Romerino M. Pizarro, M. Guzman, Sushmitha Gururagavendiran, et al.
Elsevier eBooks (2024), pp. 69-76
Closed Access
The impact of antidiabetic medications on COVID-19 outcomes in diabetic patients: an overview
Malek Zarei, Navideh Sahebi vaihan, Sepideh Shiravand, et al.
Deleted Journal (2024) Vol. 28, Iss. 4, pp. 363-388
Open Access
Malek Zarei, Navideh Sahebi vaihan, Sepideh Shiravand, et al.
Deleted Journal (2024) Vol. 28, Iss. 4, pp. 363-388
Open Access
Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic
Dan Ouchi, Carles Vilaplana-Carnerero, Vanessa de Dios, et al.
Primary care diabetes (2022) Vol. 16, Iss. 6, pp. 753-759
Open Access | Times Cited: 2
Dan Ouchi, Carles Vilaplana-Carnerero, Vanessa de Dios, et al.
Primary care diabetes (2022) Vol. 16, Iss. 6, pp. 753-759
Open Access | Times Cited: 2
The vicious cycle: a history of obesity and COVID-19
Jacek Bil, Olga Możeńska
BMC Cardiovascular Disorders (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Jacek Bil, Olga Możeńska
BMC Cardiovascular Disorders (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 2
